Skip to content
Open access

Global burden of disease for gastric cancer from 1990 to 2023 and projections of the burden to 2035

Sep 2026 · Medicine · Vol 105, pp. e50643 · 0 citations · 30 references
Medicine

TL;DR

Bayesian age-period-cohort projections indicate that by 2035, GC incidence is anticipated to reach 1,159,745, while the expected numbers of deaths and DALYs are forecasted to decline to 667,145 and 15,783,072, respectively, while the impact of GC in older age demographics is projected to increase significantly.

Abstract

Gastric cancer (GC) remains a major global health challenge, contributing substantially to cancer incidence and mortality worldwide. This study aimed to evaluate the worldwide disease burden and evolving trends of GC utilizing the Global Burden of Disease 2023 database, intending to offer a robust scientific foundation for public health policy. Utilizing pertinent information from the Global Burden of Disease 2023 database, we calculated the estimated annual percentage change to measure temporal trends. We applied age-period-cohort models to analyze the impacts of time periods and cohorts from 1990 to 2023. Additionally, we explored the correlation between the burden of GC and the socio-demographic index through frontier analysis and health inequality evaluation while forecasting future trends utilizing Bayesian age-period-cohort models. From 1990 to 2023, the global cases of GC rose by 20.04%, reaching 1262,000; the total number of deaths increased from 912,483 to 934,795; however, cancer-related disability-adjusted life years (DALYs) declined by 8.85% compared to 1990. The age-standardized incidence rate, age-standardized mortality rate, and age-standardized DALY rate of GC have generally demonstrated a downward trend since 1990. The disease burden is notably greater in males than in females. Bayesian age-period-cohort projections indicate that by 2035, GC incidence is anticipated to reach 1,159,745, while the expected numbers of deaths and DALYs are forecasted to decline to 667,145 and 15,783,072, respectively; additionally, the impact of GC in older age demographics is projected to increase significantly. Although the age-standardized incidence, mortality, and disability rates of GC have declined globally from 1990 to 2023, the absolute number of incident cases, deaths, and DALYs remains substantial, indicating a persistent global health burden. Future prevention strategies should consider differences in demographic structure, socioeconomic development, and regional disease patterns.

Read PDF

Similar papers

Open access Oct 2026

Gastric cancer burden from 1990 to 2021, Joinpoint analysis, projections to 2036, and health inequality assessment

Gastric cancer (GC) remains a major global health issue with high incidence and mortality. This study evaluates the global burden and health disparities of GC from 1990 to 2021 and projects trends through 2036, providing evidence for targeted control measures. The data were sourced from the 2021 Global Burden of Diseas...

Xin-Long Bi, Miao Yu, Jing Luan et al. · 0 citations
Sep 2026

Comprehensive analysis of colorectal cancer burden in G20 countries from 1990 to 2023 and projections to 2030: findings from the Global Burden of Disease Study 2023.

Despite substantial declines in age-standardized mortality and DALY rates, absolute CRC burden in G20 countries has increased dramatically over three decades, driven by population growth and aging.

Ke Zhang, Zhi-Fei Chen · 0 citations
Open access Oct 2026

Global trends in young and older adult esophageal cancer burden from 1990 to 2021

Esophageal cancer (EC) is the sixth leading cause of cancer-related mortality worldwide, and analyzing its most recent disease trends is essential for effective prevention and control strategies. Data on the global burden of EC were obtained from the 2021 Global Burden of Disease study, including prevalence, incidence,...

Yi-Fan Li, Guo-Peng Jiang, Xia Liu et al. · 0 citations
Open access Oct 2026

The Burden of Early-Onset Gastric Cancer From 1990 to 2021: A Systematic Analysis for the Global Burden of Disease Study 2021.

BACKGROUND Gastric cancer (GC) is a substantial global health burden, with early-onset gastric cancer (EOGC) posing distinct diagnostic and management challenges in adolescents and young adults. This study evaluated the global burden, temporal trends, and associated factors of EOGC. METHODS Using Global Burden of Dis...

Xin-Ye Cui, Yu-Zhuo Chen, Ze-Yu Jiao et al. · 0 citations
Sep 2026

Burden of cancer in China from 1990 to 2023 and projections to 2050.

An emerging structural divergence is revealed in China's cancer burden, with incidence increasingly concentrated in women and mortality in men, and the need for sex- and age-specific cancer control strategies is highlighted.

Dan Wang, Zhen-Zhen Rao, Wei Xiong et al. · 0 citations
Oct 2026

Trends and Projections of Esophageal Cancer Incidence and Mortality in China, 1990 to 2050: An Analysis of the Global Burden of Disease Study 2023.

Although China has markedly reduced the esophageal cancer burden since 1990, the post-2020 rebound in incidence calls for intensified surveillance and rapid evaluation of potential drivers.

Peng Su, Yan-Zhao Xu, Shi-Wang Wen et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.